Immunovant Inc (IMVT)
30.29
-0.58
(-1.88%)
USD |
NASDAQ |
May 21, 16:00
30.29
0.00 (0.00%)
After-Hours: 17:44
Immunovant Total Liabilities (Quarterly): 32.10M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 32.10M |
September 30, 2023 | 40.26M |
June 30, 2023 | 51.36M |
March 31, 2023 | 43.34M |
December 31, 2022 | 41.56M |
September 30, 2022 | 32.40M |
June 30, 2022 | 22.16M |
March 31, 2022 | 45.74M |
December 31, 2021 | 38.03M |
September 30, 2021 | 30.34M |
Date | Value |
---|---|
June 30, 2021 | 22.50M |
March 31, 2021 | 21.01M |
December 31, 2020 | 18.88M |
September 30, 2020 | 15.49M |
June 30, 2020 | 22.52M |
March 31, 2020 | 15.32M |
December 31, 2019 | 14.76M |
September 30, 2019 | 4.363M |
June 30, 2019 | 4.116M |
March 31, 2019 | 0.3004M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.116M
Minimum
Jun 2019
51.36M
Maximum
Jun 2023
27.17M
Average
22.52M
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
Perspective Therapeutics Inc | 48.40M |
Electromed Inc | 6.357M |
Xtant Medical Holdings Inc | 46.25M |
Asensus Surgical Inc | 27.79M |
Myomo Inc | 5.621M |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 711.45M |
Shareholders Equity (Quarterly) | 679.34M |